Novavax Inc (NVAX NASDAQ) stock market data APIs
$9.349
-0.72(-7.7%)
as of May 6, 2026
Try our APIs with
free plan!
Novavax Inc Financial Data Overview
Price chart is built with
Anychart
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Prev. Close
9.349
Open
8.63
High
9.5038
Low
8.3871
52 wk Range
5.8-11.97
Market Cap
1 539 M
P/E Ratio
3.6279
Shares Outstanding
164 M
Revenue
1 123 M
EPS
0.11
Beta
2.369
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Novavax Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novavax Inc data using free add-ons & libraries
Get Novavax Inc Fundamental Data
Novavax Inc Fundamental data includes:
- Net Revenue: 1 123 M
- EBITDA: 591 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-04
- EPS/Forecast: -0.4206
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novavax Inc News
New
Notable Wednesday Option Activity: HUT, BIOA, NVAX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Hut 8 Corp (Symbol: HUT), where a total of 71,516 contracts have traded so far, representin...
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M® in two infectious disease areas In April, Novavax signe...
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
The first-quarter 2026 reporting cycle of the Medical sector is in full swing. The sector primarily comprises pharma/biotech and medical device companies. Many pharma giants, like AbbVie and Eli Lil...
A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine Data
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Novavax (NVAX) is in focus ...
Get Novavax Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
